672 related articles for article (PubMed ID: 16442195)
21. Spatial working memory deficit correlates with disorganization symptoms and social functioning in schizophrenia.
Takahashi H; Iwase M; Nakahachi T; Sekiyama R; Tabushi K; Kajimoto O; Shimizu A; Takeda M
Psychiatry Clin Neurosci; 2005 Aug; 59(4):453-60. PubMed ID: 16048451
[TBL] [Abstract][Full Text] [Related]
22. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
[TBL] [Abstract][Full Text] [Related]
23. Social cognitive problem-solving in schizophrenia: associations with fluency and verbal memory.
Yamashita C; Mizuno M; Nemoto T; Kashima H
Psychiatry Res; 2005 Apr; 134(2):123-9. PubMed ID: 15840413
[TBL] [Abstract][Full Text] [Related]
24. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
25. Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia.
Brébion G; Amador X; Smith M; Malaspina D; Sharif Z; Gorman JM
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):177-83. PubMed ID: 10910088
[TBL] [Abstract][Full Text] [Related]
26. Deficits in neurocognition, theory of mind, and social functioning in patients with schizophrenic disorders: are they related?
Bâ MB; Zanello A; Varnier M; Koellner V; Merlo MC
J Nerv Ment Dis; 2008 Feb; 196(2):153-6. PubMed ID: 18277224
[TBL] [Abstract][Full Text] [Related]
27. Contribution of divergent thinking to community functioning in schizophrenia.
Nemoto T; Kashima H; Mizuno M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):517-24. PubMed ID: 17218048
[TBL] [Abstract][Full Text] [Related]
28. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
29. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.
Stip E; Caron J; Renaud S; Pampoulova T; Lecomte Y
Compr Psychiatry; 2003; 44(4):331-40. PubMed ID: 12923712
[TBL] [Abstract][Full Text] [Related]
30. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Gibel A; Ritsner MS
Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
[TBL] [Abstract][Full Text] [Related]
31. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
32. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
Brazo P; Delamillieure P; Morello R; Halbecq I; Marié RM; Dollfus S
Psychiatry Res; 2005 Jan; 133(1):45-55. PubMed ID: 15698676
[TBL] [Abstract][Full Text] [Related]
33. Intentionality as a link between the neuropsychology and the symptoms of schizophrenia.
Kaiser S; Weisbrod M
Psychopathology; 2007; 40(4):221-8. PubMed ID: 17396048
[TBL] [Abstract][Full Text] [Related]
34. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
35. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of verbal fluency deficit in geriatric schizophrenia.
Bowie CR; Harvey PD; Moriarty PJ; Parrella M; White L; Davis KL
Arch Clin Neuropsychol; 2004 Mar; 19(2):289-303. PubMed ID: 15010092
[TBL] [Abstract][Full Text] [Related]
37. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
Light GA; Braff DL
Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
[TBL] [Abstract][Full Text] [Related]
38. Cognitive functioning related to quality of life in schizophrenia.
Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
[TBL] [Abstract][Full Text] [Related]
39. Social functioning, theory of mind and neurocognition in outpatients with schizophrenia; mental state decoding may be a better predictor of social functioning than mental state reasoning.
Bora E; Eryavuz A; Kayahan B; Sungu G; Veznedaroglu B
Psychiatry Res; 2006 Dec; 145(2-3):95-103. PubMed ID: 17074402
[TBL] [Abstract][Full Text] [Related]
40. Relations between a computerized shopping task and cognitive tests in a group of persons diagnosed with schizophrenia compared with healthy controls.
Larøi F; Canlaire J; Mourad H; VAN DER Linden M
J Int Neuropsychol Soc; 2010 Jan; 16(1):180-9. PubMed ID: 19900350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]